Log in to search using one of your social media accounts:

This page shows you the latest news items in this category. This is page number 7.

Rheumatoid Factor Isotypes Before the Onset of RARheumatoid Factor Isotypes Before the Onset of RA
Can we predict the development of rheumatoid arthritis years before the onset of symptoms? Arthritis Research & Therapy (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 10, 2016 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

VIDEO: Smoking, excess weight hinder sustained remission in early RA
LONDON – Tobacco use and excess weight can make it harder to achieve sustained remission in the treatment of early rheumatoid arthritis, according to findings from more than 1,000 patients in the... (Source: Family Practice News)
Source: Family Practice News - June 10, 2016 Category: Primary Care Source Type: news

Disjointed: Cell differences may explain why rheumatoid arthritis varies by location
Not only are there distinct differences in key cellular processes and molecular signatures between rheumatoid arthritis (RA) and osteoarthritis (OA) but, more surprisingly, there are joint-specific differences in RA, report researchers. The findings help explain why drugs treating RA vary in effect and provide a potential new template for precisely targeting treatment for each and every ailing joint. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 10, 2016 Category: Science Source Type: news

EU wants more transparency on AbbVie's Humira, world's top drug
LONDON (Reuters) - Details of clinical trials involving AbbVie's rheumatoid arthritis drug Humira, the world's top-selling prescription medicine, are still being withheld without justification, according to the European Union's ombudsman. (Source: Reuters: Health)
Source: Reuters: Health - June 10, 2016 Category: Consumer Health News Tags: healthNews Source Type: news

Hydroxychloroquine, abatacept linked with reduced type 2 diabetes
LONDON – U.S. rheumatoid arthritis patients had a significantly reduced incidence of type 2 diabetes when on treatment with either hydroxychloroquine or abatacept in an analysis of more than 13,000... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - June 10, 2016 Category: Endocrinology Source Type: news

Obesity and smoking reduces likelihood of treatment success in early rheumatoid arthritis
Presented at the European League Against Rheumatism Annual Congress, research showed that the likelyhood of remission in early RA is significantly lower in patients who are obese or who smoke. Science Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - June 10, 2016 Category: Endocrinology Source Type: news

Positive mental attitude improves treatment adherence in rheumatoid arthritis
(European League Against Rheumatism) Positive mental attitude improves treatment adherence in rheumatoid arthritis (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 10, 2016 Category: Global & Universal Source Type: news

One third of rheumatoid arthritis patients experience sexual dysfunction
(European League Against Rheumatism) One third of rheumatoid arthritis patients experience sexual dysfunction. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 10, 2016 Category: Global & Universal Source Type: news

Disjointed: Cell differences may explain why rheumatoid arthritis varies by location
(University of California - San Diego) Researchers at the University of California San Diego School of Medicine, with colleagues in Pennsylvania and China, report that not only are there distinct differences in key cellular processes and molecular signatures between rheumatoid arthritis (RA) and osteoarthritis (OA) but, more surprisingly, there are joint-specific differences in RA. The findings help explain why drugs treating RA vary in effect and provide a potential new template for precisely targeting treatment for each and every ailing joint. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - June 10, 2016 Category: Global & Universal Source Type: news

Prolonged repetitive physical workload increases risk of developing rheumatoid arthritis
(European League Against Rheumatism) Prolonged repetitive physical workload increases risk of developing rheumatoid arthritis (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 10, 2016 Category: Global & Universal Source Type: news

Motivational text messages and counselling boost health of patients with RA
(European League Against Rheumatism) Motivational text messages and counselling boost health of patients with rheumatoid arthritis (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 10, 2016 Category: Global & Universal Source Type: news

UK rheumatologists go beyond NICE guidance on cost when treating RA patients
(European League Against Rheumatism) UK rheumatologists go beyond NICE guidance on cost when treating rheumatoid arthritis patients (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 10, 2016 Category: Global & Universal Source Type: news

Obesity and smoking reduces likelihood of treatment success in early rheumatoid arthritis
The results of a study showed that the likelihood of achieving sustained remission in early rheumatoid arthritis (RA) is significantly lower in patients who smoke and who are obese. These findings suggest that encouraging patients to stop smoking and to achieve a healthy body weight could significantly improve their chance of becoming symptom-free after adequate treatment. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 9, 2016 Category: Science Source Type: news

Gene profiling can help predict treatment response and could save money in RA
Two new studies have shown that the use of gene profiling designed to predict a positive response to treatment in rheumatoid arthritis (RA) patients is following the lead from its use in cancer treatment. Prompt identification of those RA patients not responding to treatment supports timely switching to alternative treatment, reducing the chance of long-term joint damage and avoiding money being wasted on ineffective drugs. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 9, 2016 Category: Science Source Type: news

Early, efficient detection and treatment of rheumatoid arthritis using new delivery system
The results of a new study showed that tiny particles made of a biodegradable polymer (BNPs -- biodegradable polymer nanoparticles) have the potential to enable early detection and efficient long-term treatment of rheumatoid arthritis (RA), with minimal side effects. By coating these particles with a peptide that is only able to target inflamed joint tissue, BNPs may be used to efficiently and selectively deliver drugs and diagnostic probes into arthritic joints. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 9, 2016 Category: Science Source Type: news

Osteoarthritis just as severe as rheumatoid arthritis
The results of a new study showed patients with osteoarthritis (OA) are more likely to have the impact of their condition underestimated by rheumatologists than patients with Rheumatoid Arthritis (RA). (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 9, 2016 Category: Science Source Type: news

Can Rheumatoid Arthritis Cause Hearing Loss?
When I have a patient with rheumatoid arthritis (RA), I like to test their hearing. Most doctors think I’m crazy. They don’t get the connection between your hearing and your joints. But it’s clearly there. When you have RA, your immune system mistakes your bones, cartilage, and connective tissues for hostile invaders. It attacks and breaks down the joints. The result is a crippling loss of mobility. But RA doesn’t stop at the joints. It can affect the entire body. About 15% to 25% of RA patients have “extra-articular” RA. This form of the disease can attack your heart, lungs, blood vessels, kidneys and eyes. I...
Source: Al Sears, MD Natural Remedies - June 9, 2016 Category: Complementary Medicine Authors: Al Sears Tags: Health Source Type: news

Gout Hospitalizations Outpace Those for Rheumatoid ArthritisGout Hospitalizations Outpace Those for Rheumatoid Arthritis
Despite a decline in hospitalizations related to rheumatoid arthritis, hospitalizations primarily associated with gout have increased dramatically during the last 2 decades. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 9, 2016 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Obesity and smoking reduces likelihood of treatment success in early rheumatoid arthritis
(European League Against Rheumatism) Obesity and smoking reduces likelihood of treatment success in early rheumatoid arthritis (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 9, 2016 Category: Global & Universal Source Type: news

IL-6 Blockade Stops RA Damage
(MedPage Today) -- Sirukumab inhibited radiographic progression in rheumatoid arthritis at 1 year (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - June 8, 2016 Category: Primary Care Source Type: news

Impact of Osteoarthritis Underrated by RheumatologistsImpact of Osteoarthritis Underrated by Rheumatologists
Rheumatologists are more likely to underestimate the impact of osteoarthritis than rheumatoid arthritis, even though patients with osteoarthritis often have more pain and a greater burden of disease. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 8, 2016 Category: Consumer Health News Tags: Rheumatology News Source Type: news

GSK, J&J Reveal RA Drug Phase III Results
A study of sirukumab meets both co-primary endpoints in patients with moderately to severely active rheumatoid arthritis (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - June 8, 2016 Category: Pharmaceuticals Source Type: news

PRP Therapy: Play Hard, Heal Fast
There’s a way to heal sports injuries that doesn’t involve surgery, months of physical therapy or a dependence on prescription medication. It’s called platelet-rich plasma (PRP) therapy. What Is PRP Therapy? It’s a form of stem cell treatment that uses platelets — colorless blood cells that help your blood clot — to rebuild a damaged tendon or cartilage. It not only relieves the pain, it also jumpstarts the healing process.   That’s because platelets contain hundreds of proteins called “growth factors.” The natural growth factors in PRP can actually regenerate injured tissues.1 H...
Source: Al Sears, MD Natural Remedies - June 8, 2016 Category: Complementary Medicine Authors: Al Sears Tags: Anti-Aging Source Type: news

Anti-TNF study sheds new light on how they function
In this study, the researchers observed that treating rheumatoid arthritis patients with adalimumab helped to increase the number of regulatory T cells that suppressed inflammation in the body. It was previously assumed that this was because TNF stops the development of these anti-inflammatory cells.However, the new study revealed that in actual fact, TNF actually triggers the formation of anti-inflammatory T cells, and that adalimumab is capable of enhancing this process at the same time as stopping TNF's pro-inflammatory effects.Michael Ehrenstein and colleagues at University College London said: "These results ...
Source: Arthritis Research UK - June 7, 2016 Category: Rheumatology Source Type: news

J&J, GSK rheumatoid arthritis drug meets goals of large trial
(Reuters) - An experimental drug for rheumatoid arthritis developed by Johnson & Johnson and GlaxoSmithKline slowed joint damage and improved symptoms of the disease, meeting the main goals of a large, late stage trial, according to data released on Tuesday. (Source: Reuters: Health)
Source: Reuters: Health - June 7, 2016 Category: Consumer Health News Tags: healthNews Source Type: news

Rheumatoid arthritis: clinical review
The epidemiology, aetiology, diagnosis, monitoring and treatment of rheumatoid arthritis, including the latest advice on investigations and the role of early referral and treatment in halting disease progression. (Source: GP Online Education)
Source: GP Online Education - June 7, 2016 Category: Primary Care Tags: 15.9 Rheumatology, Musculoskeletal and Trauma Source Type: news

Hunting growth, Samsung races to get up to speed on biosimilar drugs
SEOUL (Reuters) - As Samsung Bioepis raced to be first to market with a copy of Enbrel, a blockbuster rheumatoid arthritis drug, countdown clocks reminded workers - heading for lunch, meetings or even the washroom - of the days to the first mass production run. (Source: Reuters: Health)
Source: Reuters: Health - June 6, 2016 Category: Consumer Health News Tags: healthNews Source Type: news

Etanercept/methotrexate treatment for rheumatoid arthritis 'can be safely tapered'
This study adds to the growing body of evidence that in some patients who have responded well to treatment, doses could be reduced or even stopped altogether without them experiencing a change in effect. This work is still in the early stages, and it is important that people with arthritis consult their rheumatologist before reducing dosage of any prescribed medication." (Source: Arthritis Research UK)
Source: Arthritis Research UK - June 6, 2016 Category: Rheumatology Source Type: news

Rheumatoid Arthritis - Remicade
Rheumatoid Arthritis - My Doctor Says I Need Remicade (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 6, 2016 Category: Journals (General) Source Type: news

Novel Treatment Options Explored at Rheumatology CongressNovel Treatment Options Explored at Rheumatology Congress
Alternative therapies for rheumatoid arthritis, psoriatic arthritis, and systemic lupus erythematosus will be presented at the upcoming European League Against Rheumatism (EULAR) Congress 2016. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 2, 2016 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Can-Fite BioPharma to initiate Phase III trial of piclidenoson to treat rheumatoid arthritis
Can-Fite BioPharma, an advanced clinical stage drug development company, has reached an agreement with the European Medicines Agency (EMA) to design a global Phase III trial for piclidenoson (CF101), a new A3 adenosine receptor agonist (A3AR) small m… (Source: Drug Development Technology)
Source: Drug Development Technology - June 1, 2016 Category: Pharmaceuticals Source Type: news

Stay Active With RA and Keep Up the Fun
WebMD explains how some smart planning and the right moves can let you enjoy travel, evenings out, and hobbies, even if your rheumatoid arthritis flares up. (Source: WebMD Health)
Source: WebMD Health - June 1, 2016 Category: Consumer Health News Source Type: news

How to Do Household Chores When You Have RA
WebMD describes tips, tricks, and gadgets to help keep your house tidy when you have rheumatoid arthritis. (Source: WebMD Health)
Source: WebMD Health - June 1, 2016 Category: Consumer Health News Source Type: news

How to Talk to Others About Your RA
WebMD has tips on how to open up to family and friends about how your rheumatoid arthritis affects you. (Source: WebMD Health)
Source: WebMD Health - June 1, 2016 Category: Consumer Health News Source Type: news

Your Rheumatoid Arthritis When the Season Changes
Does a change in weather patterns make a difference in your RA pain? WebMD explains how to get year-round relief. (Source: WebMD Health)
Source: WebMD Health - June 1, 2016 Category: Consumer Health News Source Type: news

How to Beat Morning Pain From Rheumatoid Arthritis
WebMD gives you tips on how to ease joint stiffness and pain that can flare up at the start of your day. (Source: WebMD Health)
Source: WebMD Health - June 1, 2016 Category: Consumer Health News Source Type: news

Samsung Bioepis: Final European Approval for Remicade CopySamsung Bioepis: Final European Approval for Remicade Copy
South Korea's Samsung Bioepis said on Monday its biosimilar of Johnson & Johnson's blockbuster rheumatoid arthritis drug Remicade (infliximab) has received final approval from European regulators, paving the way for its second product launch in Europe. International Approvals (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 31, 2016 Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news

Samsung Bioepis secures EC approval to market RA biosimilar Flixabi in EU
Samsung Bioepis, a joint venture between Samsung BioLogics and Biogen, has secured approval from the European Commission (EC) to market rheumatoid arthritis (RA) biosimilar, Flixabi, in the European Union (EU). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - May 30, 2016 Category: Pharmaceuticals Source Type: news

Obesity Halves Chance for RA Remission, Study Suggests Obesity Halves Chance for RA Remission, Study Suggests
Patients with rheumatoid arthritis who were obese were only about half as likely to achieve and sustain RA remission as nonobese patients. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 30, 2016 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Samsung Bioepis receives final European approval for its Remicade copy
SEOUL (Reuters) - South Korea's Samsung Bioepis said on Monday its biosimilar of Johnson & Johnson's blockbuster rheumatoid arthritis drug Remicade has received final approval from European regulators, paving the way for its second product launch in Europe. (Source: Reuters: Health)
Source: Reuters: Health - May 30, 2016 Category: Consumer Health News Tags: healthNews Source Type: news

Tapering and Discontinuation of TNF-a Blockers in RATapering and Discontinuation of TNF-a Blockers in RA
Can clinical and ultrasound-based remission be used to select patients with rheumatoid arthritis eligible to taper and discontinue TNF-a blockers? Arthritis Research & Therapy (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 27, 2016 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Expanding our investment in the microbiome
The microbiome is increasingly recognised as influencing health and disease. To help clarify the role of the microbiome in musculoskeletal disease, last year we announced a programme of investment in this area. We’ve committed to funding ground-breaking research exploring the relationship between the microbiome and arthritis, and along with five pathfinder awards announced last year, and one prestigious programme grant announced in January, we have now invested £1.5 million in an additional two strategic awards, bringing our total investment in this area to almost £5 million. These newest awards ar...
Source: Arthritis Research UK - May 26, 2016 Category: Rheumatology Source Type: news

Turmeric: Bali’s Anti-Cancer Tonic
I’m always happy to find things in my travels to bring back to you. Today I want to tell you about a miracle of nature called turmeric. Turmeric has been used to treat a wide variety of conditions. You can read about it in-depth in my latest book, Healing Herbs of Paradise. The roots of this exotic leafy plant contain curcumin, a very powerful antioxidant that also has remarkable anti-inflammatory properties.1,2,3 What Does Curcumin Do? Curcumin neutralizes free radicals… those nasty little chemicals that travel through your body and cause damage to healthy cells and cell membranes. Which means curcumin effectivel...
Source: Al Sears, MD Natural Remedies - May 25, 2016 Category: Complementary Medicine Authors: Al Sears Tags: Cancer Source Type: news

Better Than Tylenol To Ease Arthritis Pain
No dose of Tylenol is going to ease your arthritis pain — no matter what your doctor tells you. It’s important to know the benefits and risks associated with each medication to determine which ones are right for you. And a team of researchers from the University of Bern, in Switzerland, has just proved it. The researchers gathered data from 74 randomized trials involving 58,500 patients. And what they discovered was that acetaminophen — marketed as Tylenol in America and Paracetamol in Europe, Australia and elsewhere — has no impact at all on osteoarthritis pain, no matter what the dosage. Arthritis Treatments Can ...
Source: Al Sears, MD Natural Remedies - May 25, 2016 Category: Complementary Medicine Authors: Al Sears Tags: Health Source Type: news

Stebbins, Cocohoba leading specialty drug study with Walgreens
So-called specialty drugs can represent lifesaving advances in the treatment of serious complex conditions, such as cancers, hepatitis C, rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease. They can turn once routinely lethal diseases such as HIV and cystic fibrosis into manageable chronic conditions. They can address rare genetic conditions, such as hemophilia, or suppress immune rejection after organ transplants. (Source: UCSF School of Pharmacy News)
Source: UCSF School of Pharmacy News - May 24, 2016 Category: Universities & Medical Training Authors: Paula Joyce Source Type: news

Navidea unveils refinancing plans
Navidea (NYSE:NAVB) said today it received an offer to refinance the entirity of its existing CRG loan facility. The move will allow Navidea to refinance all of its outstanding CRG debt with a facility that will allow for “substantially more financial flexibility,” the Dublin, Ohio-based company said. “While we believe we have no obligation to refinance the existing senior secured debt facility, we are pleased that investors are demonstrating support for the significant strides Navidea has taken to improve sales, right size expenses and develop an exciting portfolio of diagnostic products and therapeu...
Source: Mass Device - May 23, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Navidea Biopharmaceuticals Source Type: news

Quality of Life is the Ultimate Endpoint
Did you know that only 1 in 8 drugs in development makes it to market? It is estimated by the Manhattan Institute that $4.3 billion out of every $5.8 billion spent on research and development of new therapies is misspent. That cost is felt in time and money, but even more so in lost opportunity. It’s tragic that progress is so slow and expensive. For all of the monetary and human resources dedicated to pharmaceutical R&D, the odds remain heavily stacked against breakthrough research ever making it to market. There’s even a name for this phenomenon: Eroom’s Law, the opposite of Moore’s, in spelling and effect al...
Source: EyeForPharma - May 23, 2016 Category: Pharmaceuticals Authors: Daphne Kis Source Type: news

Antiaging Yoga
by guest blogger Holly Walck Kostura, BSN and certified Iyengar Yoga teacher To quote Webster's: "Aging (adj): (of a thing) reaching the end of useful life; growing old or older, especially visibly and obviously so; obsolescent Obsolescent (adj): becoming obsolete Obsolete (adj): no longer produced or used; out-of-date." When I was 22 years old, a friend and I went into a local bookstore and saw a display of exercise videos, including one titled, Yoga for Beginners. The middle-aged woman demonstrating the pose on the cover looked strong, stable, flexible, and joyful, and I remember knowing that the way she looked WAS ...
Source: Healthy Living - The Huffington Post - May 20, 2016 Category: Consumer Health News Source Type: news

Charlotte’s story: Overcoming lupus
A few months ago, Bonnie Godas, a Braintree mother of two, called a friend at the Massachusetts Statehouse asking a simple question. That friend phoned a friend at the Massachusetts Department of Transportation. Several phones calls later, Bonnie heard the news. On May 21, Boston’s iconic Zakim Bridge will be lit purple in recognition of Lupus Awareness Month. “I’m excited. I’m grateful and thrilled that Charlotte is doing so well,” says Bonnie. “It’s so important for parents to know about lupus because it can mask itself as other conditions like fibromyalgia and rheumatoid arthritis.” Lupus is an unpredict...
Source: Thrive, Children's Hospital Boston - May 20, 2016 Category: Pediatrics Authors: Lisa Fratt Tags: Diseases & Conditions Teen Health Dr. Robert Sundel lupus rheumatology program Source Type: news

Should Rosacea Patients Be Screened for Autoimmune Diseases?Should Rosacea Patients Be Screened for Autoimmune Diseases?
Dr Graeme Lipper reviews a population-based case-control study that explored the link between rosacea, type 1 diabetes, celiac disease, multiple sclerosis, and rheumatoid arthritis. Medscape Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 20, 2016 Category: Consumer Health News Tags: Dermatology Viewpoint Source Type: news